BACKGROUND: The rise in LDL with egg feeding in lean insulin-sensitive (LIS) participants is 2- and 3-fold greater than in lean insulin-resistant (LIR) and obese insulin-resistant (OIR) participants, respectively. OBJECTIVE: We determined whether differences in cholesterol absorption, synthesis, or both could be responsible for these differences by measuring plasma sterols as indexes of cholesterol absorption and endogenous synthesis. DESIGN:Plasma sterols were measured by gas chromatography-mass spectrometry in a random subset of 34 LIS, 37 LIR, and 37 OIR participants defined by the insulin sensitivity index (S(I)) and by BMI criteria selected from a parent group of 197 participants. Cholestanol and plant sterols provide a measure of cholesterol absorption, and lathosterol provides a measure of cholesterol synthesis. RESULTS: The mean (±SD) ratio of plasma total absorption biomarker sterols to cholesterol was 4.48 ± 1.74 in LIS, 3.25 ± 1.06 in LIR, and 2.82 ± 1.08 in OIR participants. After adjustment for age and sex, the relations of the absorption sterol-cholesterol ratios were as follows: LIS > OIR (P < 0.001), LIS > LIR (P < 0.001), and LIR > OIR (P = 0.11). Lathosterol-cholesterol ratios were 0.71 ± 0.32 in the LIS participants, 0.95 ± 0.47 in the LIR participants, and 1.29 ± 0.55 in the OIR participants. After adjustment for age and sex, the relations of lathosterol-cholesterol ratios were as follows: LIS < OIR (P < 0.001), LIS < LIR (P = 0.03), and LIR < OIR (P = 0.002). Total sterol concentrations were positively associated with S(I) and negatively associated with obesity, whereas lathosterol correlations were the opposite. CONCLUSIONS:Cholesterol absorption was highest in the LIS participants, whereas cholesterol synthesis was highest in the LIR and OIR participants. Therapeutic diets for hyperlipidemia should emphasize low-cholesterol diets in LIS persons and weight loss to improve S(I) and to decrease cholesterol overproduction in LIR and OIR persons.
RCT Entities:
BACKGROUND: The rise in LDL with egg feeding in lean insulin-sensitive (LIS) participants is 2- and 3-fold greater than in lean insulin-resistant (LIR) and obese insulin-resistant (OIR) participants, respectively. OBJECTIVE: We determined whether differences in cholesterol absorption, synthesis, or both could be responsible for these differences by measuring plasma sterols as indexes of cholesterol absorption and endogenous synthesis. DESIGN: Plasma sterols were measured by gas chromatography-mass spectrometry in a random subset of 34 LIS, 37 LIR, and 37 OIR participants defined by the insulin sensitivity index (S(I)) and by BMI criteria selected from a parent group of 197 participants. Cholestanol and plant sterols provide a measure of cholesterol absorption, and lathosterol provides a measure of cholesterol synthesis. RESULTS: The mean (±SD) ratio of plasma total absorption biomarker sterols to cholesterol was 4.48 ± 1.74 in LIS, 3.25 ± 1.06 in LIR, and 2.82 ± 1.08 in OIR participants. After adjustment for age and sex, the relations of the absorption sterol-cholesterol ratios were as follows: LIS > OIR (P < 0.001), LIS > LIR (P < 0.001), and LIR > OIR (P = 0.11). Lathosterol-cholesterol ratios were 0.71 ± 0.32 in the LISparticipants, 0.95 ± 0.47 in the LIR participants, and 1.29 ± 0.55 in the OIR participants. After adjustment for age and sex, the relations of lathosterol-cholesterol ratios were as follows: LIS < OIR (P < 0.001), LIS < LIR (P = 0.03), and LIR < OIR (P = 0.002). Total sterol concentrations were positively associated with S(I) and negatively associated with obesity, whereas lathosterol correlations were the opposite. CONCLUSIONS:Cholesterol absorption was highest in the LISparticipants, whereas cholesterol synthesis was highest in the LIR and OIR participants. Therapeutic diets for hyperlipidemia should emphasize low-cholesterol diets in LISpersons and weight loss to improve S(I) and to decrease cholesterol overproduction in LIR and OIR persons.
Authors: Richard E Ostlund; Janet B McGill; Chun-Min Zeng; Douglas F Covey; Jay Stearns; William F Stenson; Curtis A Spilburg Journal: Am J Physiol Endocrinol Metab Date: 2002-04 Impact factor: 4.310
Authors: Thomas M van Himbergen; Nirupa R Matthan; Nancy A Resteghini; Seiko Otokozawa; Masumi Ai; Evan A Stein; Peter H Jones; Ernst J Schaefer Journal: J Lipid Res Date: 2008-11-30 Impact factor: 5.922
Authors: Laura Calpe-Berdiel; Noemí Rotllan; Catherine Fiévet; Rosa Roig; Francisco Blanco-Vaca; Joan Carles Escolà-Gil Journal: J Lipid Res Date: 2008-05-28 Impact factor: 5.922
Authors: Nirupa R Matthan; Michael Pencina; Jane M LaRocque; Paul F Jacques; Ralph B D'Agostino; Ernst J Schaefer; Alice H Lichtenstein Journal: J Lipid Res Date: 2009-05-12 Impact factor: 5.922
Authors: Anas Mohamad Hashem; Lizeth Cifuentes; Gerardo Calderon; Maria Laura Ricardo-Silgado; Daniel Gonzalez-Izundegui; Alejandro Campos; Alison McRae; Shawna Franks; Maria Daniela Hurtado; Duane Burton; Xuan-Mai Petterson; Ian R Lanza; Michael Camilleri; Andres Acosta Journal: Am J Physiol Gastrointest Liver Physiol Date: 2022-06-21 Impact factor: 4.871
Authors: Lily Jakulj; Hussein Mohammed; Theo H van Dijk; Theo Boer; Scott Turner; Albert K Groen; Maud N Vissers; Erik S G Stroes Journal: J Lipid Res Date: 2012-11-25 Impact factor: 5.922
Authors: Steven C Moore; Charles E Matthews; Joshua N Sampson; Rachael Z Stolzenberg-Solomon; Wei Zheng; Qiuyin Cai; Yu Ting Tan; Wong-Ho Chow; Bu-Tian Ji; Da Ke Liu; Qian Xiao; Simina M Boca; Michael F Leitzmann; Gong Yang; Yong Bing Xiang; Rashmi Sinha; Xiao Ou Shu; Amanda J Cross Journal: Metabolomics Date: 2014-04-01 Impact factor: 4.290
Authors: Nirupa R Matthan; Lei Zhu; Michael Pencina; Ralph B D'Agostino; Ernst J Schaefer; Alice H Lichtenstein Journal: J Am Heart Assoc Date: 2013-02-19 Impact factor: 5.501
Authors: Camila C Leança; Valéria S Nunes; Natália B Panzoldo; Vanessa S Zago; Eliane S Parra; Patrícia M Cazita; Matti Jauhiainen; Marisa Passarelli; Edna R Nakandakare; Eliana C de Faria; Eder C R Quintão Journal: Cardiovasc Diabetol Date: 2013-11-22 Impact factor: 9.951